Endoscopic sleeve gastroplasty: a narrative review on historical evolution, physiology, outcomes, and future standpoints / 中华医学杂志(英文版)
Chinese Medical Journal
;
(24): 774-778, 2022.
Artículo
en Inglés
| WPRIM
| ID: wpr-927567
ABSTRACT
Since its first description in 2013, robust evidence supporting the efficacy and safety of the endoscopic sleeve gastroplasty (ESG) has been on the rise. A large case series and meta-analysis report supported results up to 24 months, while some other studies already described 5-year data. If associated with pharmacotherapy, the ESG may help one to achieve weight loss similar to that of surgical sleeve gastrectomy. Though the results of the ongoing randomized trials on ESG are awaited, currently available data support the clinical use of the ESG, especially for patients who are refusing or unfit for bariatric surgery.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Obesidad Mórbida
/
Gastroplastia
/
Resultado del Tratamiento
/
Laparoscopía
/
Gastrectomía
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Humanos
Idioma:
Inglés
Revista:
Chinese Medical Journal
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS